Skip to main content
Shimadzu Corporation logo

Shimadzu Corporation — Investor Relations & Filings

Ticker · 7701 ISIN · JP3357200009 LEI · 353800Y64Z08WEH8PH97 T Manufacturing
Open in API
Filings indexed 80 across all filing types
Latest filing 2022-07-13 M&A Activity
Country JP Japan
Listing T 7701

About Shimadzu Corporation

https://www.shimadzu.com/

Shimadzu Corporation is a global manufacturer of precision instruments, specializing in analytical and measuring technologies. The company's core product lines include chromatographs, mass spectrometers, spectrophotometers, and material testing machines, serving a wide range of research and industrial sectors. In addition to its analytical instruments division, Shimadzu develops and provides advanced medical systems, such as diagnostic imaging equipment, and various industrial machinery, including turbomolecular pumps and hydraulic equipment. The company's solutions support advancements in diverse fields such as healthcare, pharmaceuticals, life sciences, environmental analysis, and materials science, contributing to scientific progress and societal well-being.

Recent filings

Filing Released Lang Actions
訂正公開買付届出書
M&A Activity Classification · 100% confidence The document is a 'Correction of the Tender Offer Registration Statement' (訂正公開買付届出書) filed by Shimadzu Corporation regarding the acquisition of Nissui Pharmaceutical Co., Ltd. It details the terms of the tender offer, the background of the transaction, and the extension of the tender offer period due to regulatory filings. This is a formal regulatory filing related to a tender offer (M&A activity), which falls under the 'M&A Activity' category.
2022-07-13 Japanese
訂正公開買付届出書
M&A Activity Classification · 100% confidence The document is a 'Correction of Tender Offer Registration Statement' (訂正公開買付届出書) filed by Shimadzu Corporation regarding the acquisition of Nissui Pharmaceutical Co., Ltd. It details the terms, conditions, and background of the tender offer, including the tender offer price, the relationship between the parties, and the subsequent squeeze-out procedures. This is a formal regulatory filing related to a tender offer (M&A activity).
2022-06-29 Japanese
確認書
Regulatory Filings Classification · 100% confidence The document is titled '確認書' (Confirmation Letter) and explicitly states it is filed under the Financial Instruments and Exchange Act Article 24-4-2, Paragraph 1. It serves as an officer certification confirming the accuracy of the company's Annual Securities Report (有価証券報告書). According to the 'CERTIFICATION RULE', documents that are primarily officer certifications or attestations should be classified as Regulatory Filings (RNS), even if they reference a specific report type. FY 2022
2022-06-29 Japanese
内部統制報告書－第159期(令和3年4月1日－令和4年3月31日)
Governance Information Classification · 100% confidence The document is an 'Internal Control Report' (内部統制報告書) filed under the Financial Instruments and Exchange Act (金融商品取引法) in Japan. This type of report is a mandatory regulatory filing that assesses the effectiveness of a company's internal controls over financial reporting. Since it is a specific regulatory requirement and does not fit into categories like Annual Report (10-K), Earnings Release (ER), or others, it is best classified as a Regulatory Filing (RNS).
2022-06-29 Japanese
有価証券報告書－第159期(令和3年4月1日－令和4年3月31日)
Annual Report Classification · 100% confidence The document is a Japanese 'Yuka Shoken Hokokusho' (Securities Report), which is the Japanese equivalent of a 10-K annual report. It contains the standard regulatory header, fiscal year information (2021-04-01 to 2022-03-31), and extensive XBRL-like tagging for financial statements and corporate data. It is a comprehensive annual filing, not an announcement or a summary. FY 2022
2022-06-29 Japanese
訂正公開買付届出書
M&A Activity Classification · 100% confidence The document is a 'Correction of Tender Offer Registration Statement' (訂正公開買付届出書) filed by Shimadzu Corporation regarding the acquisition of Nissui Pharmaceutical Co., Ltd. This is a formal regulatory filing required under the Financial Instruments and Exchange Act of Japan for tender offers. It details the terms, conditions, and background of the acquisition. It is not a report publication announcement (RPA) because it is the primary legal document itself, nor is it a simple RNS. It falls under the category of M&A activity (TAR) as it pertains to a takeover bid/tender offer.
2022-06-22 Japanese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.